NCT01115205

Brief Summary

The purpose of the study is to evaluate the impact of an exercise programme organized into supervised walking groups on metabolic control, functional capacity and overall quantity of physical activity in subjects with type 2 diabetes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started Mar 2006

Typical duration for not_applicable type-2-diabetes

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2009

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2010

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 4, 2010

Completed
Last Updated

May 5, 2010

Status Verified

May 1, 2010

Enrollment Period

1.8 years

First QC Date

April 26, 2010

Last Update Submit

May 3, 2010

Conditions

Keywords

Exercise, Walking, Type 2 diabetes, Therapy

Outcome Measures

Primary Outcomes (1)

  • Change in haemoglobin A1c (HbA1c) levels

    The measurement of HbA1c is carried out with a DCCT-aligned method.

    4 months

Secondary Outcomes (12)

  • Change in Body weight

    4 months

  • Change in Fasting plasma glucose levels

    4 months

  • Change in Total Cholesterol levels

    4 months

  • Change in HDL Cholesterol levels

    4 months

  • Change in LDL Cholesterol levels

    4 months

  • +7 more secondary outcomes

Study Arms (2)

Supervised walking groups

EXPERIMENTAL

Patients included in walking groups, under the supervision of a qualified personal trainer.

Behavioral: Supervised walking

Controls

ACTIVE COMPARATOR

Patients receiving the standard counselling procedures of the Verona Diabetic Clinic.

Behavioral: Standard counselling procedure

Interventions

Walk training, 3 sessions per week for 4 months, under the supervision of a qualified personal trainer.

Supervised walking groups

Verbal and written information about the benefits of exercise and instructions aimed to encourage physical activity. In addition, one group session of counselling on these issues.

Controls

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diabetes known for at least 2 yr
  • physical inactivity
  • haemoglobin (Hb)A1c between 6.5-9.9%
  • treatment with oral hypoglycaemic agents alone or associated with a bed-time insulin injection
  • willingness to participate in a programme of regular physical activity

You may not qualify if:

  • moderate-severe autonomic or somatic neuropathy
  • severe lower limb vasculopathy
  • pre-proliferative or proliferative active retinopathy
  • moderate to severe chronic renal failure
  • unstable angina or recent (in the previous 3 months) myocardial infarction
  • acute intercurrent diseases
  • acute metabolic decompensation (blood glucose \>300 mg/dl or ketonuria in two consecutive checks)
  • use of beta-blocker drugs
  • subjects unable to complete a 6-min walk test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Negri C, Bacchi E, Morgante S, Soave D, Marques A, Menghini E, Muggeo M, Bonora E, Moghetti P. Supervised walking groups to increase physical activity in type 2 diabetic patients. Diabetes Care. 2010 Nov;33(11):2333-5. doi: 10.2337/dc10-0877.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Motor Activity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Study Officials

  • Paolo Moghetti, M.D., Ph.D.

    Universita di Verona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 26, 2010

First Posted

May 4, 2010

Study Start

March 1, 2006

Primary Completion

January 1, 2008

Study Completion

January 1, 2009

Last Updated

May 5, 2010

Record last verified: 2010-05